Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in Belgium, in Czechia, in Spain, .... It is testing Paliperidone Palmitate 3 Month and 1 Month Formulations for schizophrenia.
In Czech RepublicThis study is completed in Romania. It is testing Paliperidone Palmitate 3 Month Formulation for schizophrenia.
In Romania
This study is completed. It focuses on Bipolarity.
Location not clearly listedThis study is completed in China. It is testing intramuscular Ziprasidone for Schizophrenia.
Multiple locations, including BaodingThis study is completed in France, in Belgium, in the Netherlands, .... It focuses on Depression.
In NetherlandsThis study is completed in Czechia. It is testing asenapine for Schizophrenia.
In Czech RepublicThis study is ongoing in Germany. It is testing central cannabinoid (CB1) receptor antagonist rimonabant for schizophrenia.
In GermanyThis study is completed in the United States. It focuses on Addiction.
Multiple locations, including Lafayette
This study is completed in the United States. It focuses on PTSD.
In San DiegoThis study is completed in Germany, in Poland, and in Italy. It is testing safety and efficacy of intravenous PCN-101 for treatment-resistant depression.
In GermanyThis study is completed in Germany. It focuses on ADHD.
In GermanyThis study is ongoing in Spain and in Poland. It is testing JNJ-55308942 for depression in bipolarity.
In SpainHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.